Equibles does not estimate personal net worth.
Get an email with a short summary when Jade Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get JBIO alertsBradford Dahms is recorded as CFO at Jade Biosciences, Inc. (JBIO). The newest filing on record that lists Bradford Dahms as CFO at Jade Biosciences, Inc. (JBIO) is dated April 28, 2026. Jade Biosciences, Inc. reported in an 8-K filed July 1, 2025 that Bradford Dahms was appointed Chief Financial Officer and Treasurer, effective July 14, 2025. The proxy statement of Jade Biosciences, Inc. reports total compensation of $4,131,991 for Bradford Dahms in fiscal 2025, including a base salary of $233,013. Bradford Dahms has spoken on 1 investor event across 1 company, most recently for Jade Biosciences, Inc. on September 14, 2026. Jade Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jade Biosciences, Inc. includes Tom Frohlich (CEO and Board Member), Eric Dobmeier (Chairman and Board Member), Benjamin T. Dake (COO) and 7 others.
“On June 25, 2025, the Company appointed Bradford Dahms as Chief Financial Officer and Treasurer of the Company, effective as of July 14, 2025 (the "Effective Date").”
Start not stated–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Jade Biosciences, Inc. (JBIO) | Chief Financial Officer | $233,013 | $4,131,991 |
